Garenoxacin Mesylate hydrate (BMS284756 (Mesylate hydrate)) |
Catalog No.GC33950 |
El hidrato de mesilato de garenoxacina (BMS284756) es un antibiÓtico de quinolona activo por vÍa oral y tiene un amplio espectro de actividad contra una amplia gama de bacterias grampositivas y gramnegativas, anaerobios y organismos fastidiosos.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 223652-90-2
Sample solution is provided at 25 µL, 10mM.
Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.
[1]. Waites KB, et al. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother. 2003 Jan;47(1):161-5. [2]. Ince D, et al. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother. 2002 Nov;46(11):3370-80. [3]. Zhao X, et al. Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003 Mar;47(3):1023-7.
Average Rating: 5
(Based on Reviews and 8 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *